Casirivimab and Imdevimab Drug Combination

DRUG2 trials

Sponsors

University of Milano Bicocca, Mansoura University Hospital

Conditions

COVID-19

Phase 4

Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients

CompletedNCT05502081

Mansoura University HospitalCOVID-19

Start: 2022-09-02End: 2022-12-28Updated: 2023-07-25

Unknown Phase

COVID-19 and Disease Progression to the Severe Form: a Study on the Use of Monoclonal Antibodies Against SARS-CoV-2

CompletedNCT05268601

University of Milano BicoccaCOVID-19

Start: 2021-10-14End: 2023-12-22Updated: 2025-03-30

Related Papers

The effect of combination treatment with casirivimab and imdevimab versus standard antiviral therapy on clinical outcomes in hospitalized COVID-19 patients

Discover Medicine2024-10-141 citations

Clinical study to compare the efficacy and safety of casirivimab & imdevimab, remdesivir, and favipravir in hospitalized COVID-19 patients

Journal of Clinical Virology Plus2023-05-1010 citations